Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invictus MD Strategies Corp (GENE.VN)

Invictus MD Strategies Corp (GENE.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 20,556
  • Shares Outstanding, K 124,583
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 3.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.21
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.38
  • Most Recent Earnings -0.10 on 07/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.108 on 11/17/16
  • Sectors:

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.125 +28.00%
on 10/31/19
0.165 -3.03%
on 11/11/19
unch (unch)
since 10/11/19
3-Month
0.125 +28.00%
on 10/31/19
0.380 -57.89%
on 08/12/19
-0.175 (-52.24%)
since 08/09/19
52-Week
0.125 +28.00%
on 10/31/19
1.520 -89.47%
on 11/16/18
-1.220 (-88.41%)
since 11/09/18

Most Recent Stories

More News
Cannabis Stocks Are "No Place to Put Your Money" Reviewers Warn

USA News Group - While it may appear very enticing to jump in on the legalization of cannabis by investing in the sector, leading reviewers are coming out strong against putting your money in pot stocks....

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
CXXI.CN : 0.670 (+19.64%)
CXXIF : 0.5000 (+19.05%)
BE.CN : 0.040 (+14.29%)
BLEVF : 0.0338 (-2.03%)
ICNB : 0.6300 (+0.17%)
INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
Invictus MD Strategies Corp. Opens the Market

TORONTO , Aug. 19, 2019 /CNW/ - Trevor Dixon , Chief Executive Officer, Invictus MD Strategies Corp. (GENE), joined Steven Mills, Head, Company Services, Toronto Stock Exchange and TSX Venture...

GENE.VN : 0.160 (-3.03%)
ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
Savvy Investors Seek out Innovative Cannabis Opportunities

The booming cannabis industry has created opportunities for many driven entrepreneurs. In particular, many may be looking to launch something standard such as operating a retail dispensary or starting...

STZ : 184.52 (-1.62%)
BKLLF : 0.0181 (+15.29%)
CODE.CN : 0.025 (unch)
IGC : 0.88 (-1.12%)
CBWTF : 0.5521 (-5.20%)
XLY.VN : 0.740 (-2.63%)
CNAB : 0.3221 (-0.03%)
IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
Invictus announces Annual General Meeting Results

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
Invictus announces Closing of Non-Brokered Private Placement

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)
Invictus announces Non-Brokered Private Placement

EQNX::TICKER_START (TSX-V:GENE),(Other OTC:IVITF),(Boerse Frankfurt - Freiverkehr:8IS2), EQNX::TICKER_END

IVITF : 0.1207 (+0.25%)
GENE.VN : 0.160 (-3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.167
1st Resistance Point 0.163
Last Price 0.160
1st Support Level 0.158
2nd Support Level 0.157

See More

52-Week High 1.520
Fibonacci 61.8% 0.987
Fibonacci 50% 0.822
Fibonacci 38.2% 0.658
Last Price 0.160
52-Week Low 0.125

See More

Business Summary

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations (ACMPR) having investment in Acreage Pharms Ltd., located in West-Central Alberta, and investment in AB Laboratories Inc., located near Hamilton,...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar